Blood-brain barrier breakthrough for ALS and Alzheimer’s disease
A new blood-brain barrier-crossing platform enables the delivery of therapeutic molecules to the brain, offering potential treatments for ALS and Alzheimer’s disease.
List view / Grid view
A new blood-brain barrier-crossing platform enables the delivery of therapeutic molecules to the brain, offering potential treatments for ALS and Alzheimer’s disease.
Columbia-led team wins research grant to create fundamentally new maps that will chart cell diversity throughout the brains of humans.
Analysis of large data sets from post-mortem brain samples of people with and without Alzheimer's disease has revealed new evidence that viral species, particularly herpesviruses, may have a role in Alzheimer’s disease biology.
Researchers have identified the first case of a patient with Parkinson's disease carrying a mutation in the ACMSD gene...
31 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Using advanced stem cell technology, scientists from the Icahn School of Medicine at Mount Sinai have created a model of a heart condition called hypertrophic cardiomyopathy (HCM), an excessive thickening of the heart that is associated with a number of rare and common illnesses, some of which have a strong…